These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 37290595

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction.
    Esposito G, Cappetta D, Russo R, Rivellino A, Ciuffreda LP, Roviezzo F, Piegari E, Berrino L, Rossi F, De Angelis A, Urbanek K.
    Br J Pharmacol; 2017 Nov; 174(22):4070-4086. PubMed ID: 27922176
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats.
    Zhu ZD, Ye JM, Fu XM, Wang XC, Ye JY, Wu XR, Hua P, Liao YQ, Xuan W, Duan JL, Li WY, Fu H, Xia ZH, Zhang X.
    Int J Mol Med; 2019 Feb; 43(2):749-760. PubMed ID: 30569164
    [Abstract] [Full Text] [Related]

  • 8. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B, Möller-Ehrlich K, Kress T, Kniepert J, Schwedhelm E, Böger RH, Wanner C, Sauvant C, Schneider R.
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [Abstract] [Full Text] [Related]

  • 9. Novel Potentials of the DPP-4 Inhibitor Sitagliptin against Ischemia-Reperfusion (I/R) Injury in Rat Ex-Vivo Heart Model.
    Al-Awar A, Almási N, Szabó R, Takacs I, Murlasits Z, Szűcs G, Török S, Pósa A, Varga C, Kupai K.
    Int J Mol Sci; 2018 Oct 18; 19(10):. PubMed ID: 30340421
    [Abstract] [Full Text] [Related]

  • 10. Ammonia Reduces Intracellular Asymmetric Dimethylarginine in Cultured Astrocytes Stimulating Its y⁺LAT2 Carrier-Mediated Loss.
    Milewski K, Bogacińska-Karaś M, Fręśko I, Hilgier W, Jaźwiec R, Albrecht J, Zielińska M.
    Int J Mol Sci; 2017 Nov 02; 18(11):. PubMed ID: 29099056
    [Abstract] [Full Text] [Related]

  • 11. Protective effects of low-dose rosuvastatin on isoproterenol-induced chronic heart failure in rats by regulation of DDAH-ADMA-NO pathway.
    Zhou R, Ma P, Xiong A, Xu Y, Wang Y, Xu Q.
    Cardiovasc Ther; 2017 Apr 02; 35(2):. PubMed ID: 27957828
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sitagliptin alleviated myocardial remodeling of the left ventricle and improved cardiac diastolic dysfunction in diabetic rats.
    Liu YS, Huang ZW, Wang L, Liu XX, Wang YM, Zhang Y, Zhang M.
    J Pharmacol Sci; 2015 Mar 02; 127(3):260-74. PubMed ID: 25837922
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway.
    Tan B, Jiang DJ, Huang H, Jia SJ, Jiang JL, Hu CP, Li YJ.
    Vascul Pharmacol; 2007 May 02; 46(5):338-45. PubMed ID: 17293168
    [Abstract] [Full Text] [Related]

  • 17. Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes.
    Mikhail N.
    Expert Opin Investig Drugs; 2008 Jun 02; 17(6):845-53. PubMed ID: 18491986
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats.
    Wakino S, Hayashi K, Tatematsu S, Hasegawa K, Takamatsu I, Kanda T, Homma K, Yoshioka K, Sugano N, Saruta T.
    Hypertens Res; 2005 Mar 02; 28(3):255-62. PubMed ID: 16097370
    [Abstract] [Full Text] [Related]

  • 20. Lack of preservation of insulin gene expression by a glucagon-like peptide 1 agonist or a dipeptidyl peptidase 4 inhibitor in an in vivo model of glucolipotoxicity.
    Fontés G, Hagman DK, Latour MG, Semache M, Poitout V.
    Diabetes Res Clin Pract; 2010 Mar 02; 87(3):322-8. PubMed ID: 20092903
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.